Table 2.
Bivariate Analyses of all Hypertensive disorders (HD) and Preeclampsia and Eclampsia (PE/E) by covariates of interest
| Covariates | Strata | HD N=73 (%) | No HD N=1440 (%) | P1 | PE/E N=35 (%) | No PE/E N=1478 (%) | P1 |
|---|---|---|---|---|---|---|---|
| Maternal age | <20 | 2 (2.0) | 97 (98.0) | 0.04 | 1 (1.0) | 98 (99.0) | 0.09 |
| 20-34 | 52 (4.4) | 1124 (95.6) | 24 (2.0) | 1152 (98.0) | |||
| ≥35 | 19 (8.0) | 219 (92.0) | 10 (4.2) | 228 (95.8) | |||
|
| |||||||
| Gainfully employed | Yes | 27 (6.8) | 372 (93.2) | 0.04 | 13 (3.2) | 386 (96.7) | 0.17 |
| No | 46 (4.1) | 1068 (95.9) | 22 (2.0) | 1092 (98.0) | |||
|
| |||||||
| Marital status2 | Married | 61 (5.5) | 1042 (94.5) | 0.05 | 27 (2.5) | 1076 (97.5) | 0.57 |
| Single | 12 (2.9) | 398 (97.1) | 8 (2.0) | 402 (98.0) | |||
|
| |||||||
| Previous history of PE/E | Yes | 3 (15.0) | 17 (85.0) | 0.07 | 3 (15.0) | 17 (85.0) | 0.01 |
| No | 70 (4.7) | 1423 (95.3) | 32 (2.1) | 1461 (97.9) | |||
|
| |||||||
| Gestational age adjusted BMI at enrollment (gBMI) | <20 | 4 (1.6) | 241 (98.4) | < 0.01 | 2 (0.8) | 243 (99.2) | <0.01 |
| 20-24 | 25 (3.3) | 736 (96.7) | 12 (1.6) | 749 (98.4) | |||
| ≥25 | 43 (8.8) | 444 (91.2) | 20 (4.1) | 467 (95.9) | |||
|
| |||||||
| Trimester3 at enrollment | 1st | 7 (9.9) | 64 (90.1) | 0.10 | 4 (5.6) | 67 (94.4) | 0.12 |
| 2nd | 30 (5.1) | 561 (94.9) | 15 (2.5) | 576 (97.5) | |||
| 3rd | 36 (4.2) | 815 (95.8) | 16 (1.9) | 835 (98.1) | |||
|
| |||||||
| Creatinine at Enrollment | ≤ 1 | 69 (4.7) | 1397 (95.3) | 0.14 | 33 (2.2) | 1433 (97.8) | 0.28 |
| >1 | 2 (14.3) | 12 (85.7) | 1 (7.1) | 13 (92.9) | |||
|
| |||||||
| Hemoglobin at enrollment (g/dL) | <11 | 26 (3.7) | 682 (96.3) | 0.04 | 10 (1.4) | 698 (98.6) | 0.03 |
| ≥11 | 47 (6.1) | 730 (93.9) | 25 (3.2) | 752 (96.8) | |||
|
| |||||||
| Hemoglobin after delivery (g/dL) | <11 | 21 (3.1) | 655 (96.9) | <0.01 | 8 (1.2) | 668 (98.8) | 0.01 |
| ≥11 | 52 (6.4) | 762 (93.6) | 27 (3.3) | 787 (96.7) | |||
|
| |||||||
| Type of ART4 at conception | HAART | 21 (7.1) | 273 (92.9) | 0.04 | 13 (4.4) | 281 (95.6) | <0.01 |
| No HAART | 52 (4.3) | 1167 (95.7) | 22 (1.8) | 1197 (98.2) | |||
|
| |||||||
| ART: 1st trimester | HAART | 24 (6.6) | 338 (93.4) | 0.07 | 13 (3.6) | 349 (96.4) | 0.07 |
| No HAART | 49 (4.2) | 1102 (95.7) | 22 (1.9) | 1129 (98.1) | |||
1
P value obtained using Fisher’s exact testing,
2
Marital status divided into Married(includes living with partner) and Single (includes divorced and widowed),
3
Trimester of pregnancy defined as follows: 1st (1-12 weeks gestation), 2nd (13-26 weeks gestation), 3rd (27+weeks gestation),
4
Type of antiretroviral therapy (ART) divided into: HAART (including use of any PI) and no HAART (includes any mono, dual, triple therapy and no therapy)
All covariates with p<.2 considered in logistic regression modeling